Bioavailability research of solid medicinal forms by the example of bisoprolol fumarate tablets in relation to the biopharmaceutical classification system
Keywords:biopharmaceutical classification system, solid medicinal forms of industrial production, kinetics of release, physical and chemical properties of active substances, biowaiver, bioequivalence
The place and role of the biopharmaceutical classification system have been substantiated in the article, the essence and content of biowaiver have been revealed, as well as their use in pharmaceutical development of bioequivalent solid dosage forms has been described. A new direction has been presented. It is discovery and study of physical and chemical regularities of using active pharmaceutical ingredients, which influence on their pharmacological action. The dependence of the active substance on technological factors, i.e. features of the pharmaceutical technology, has been studied. It has become possible due to the use of modern perfect methods of estimation of drug efficiency and mainly the possibility of determination of the content of active substances and their metabolites in biological fluids, and it is necessary when considering a question about the therapeutic equivalence of medicines. On the example of the active substance – bisoprolol fumarate, which belongs to class I in accordance with the biopharmaceutical classification system, the kinetics of release and bioequivalence have been studied. The kinetics of release of the active substance of 10 mg tablets of bisoprolol fumarate and the corresponding original medicine “Concor tablets, 10 mg” has been studied in the рН medium of 1.2; 4.5; 6.8. It has been proven that development of a new medicinal form is a difficult process of the experimental research, therefore, for optimization of development of the composition and technology of medicines under conditions of the laboratory of industrial pharmacy it is necessary to use the most effective methods and methods of biopharmaceutical research, one of which is the research of bioequivalence of solid dosage forms based on the study of physical and chemical properties of active substances using the biopharmaceutical classification system.
Головенко М.Я., Баула О.П., Борисюк І.Ю. Біофармацевтична класифікаційна система. – К., 2010. – 300 с.
Кондратенко С.Н. Фармакокинетические факторы абсорбции лекарственных препаратов: Дисс. … докт. фарм. наук. – М., 2003. – 287 с.
Перцев І.М., Рубан О.А., Тамм Т.І., Дмитрієвський Д.І. // Щотижневик «Аптека». – 2012. – №23 (844). – С. 8.
Тенцова А.И. // Фармация. – 2012. – №3. – С. 3-4.
Bioequivalence of bisoprolol fumarate tablets in healthy volunteers[J] / ZHOU Xia~1 DING Li~1 HE Jianchang~ 2 XU Gui-li~2 GUO Xiao-feng~1 CHEN Guo-wei~1 1 Department of Pharmaceutical Analysis, China Pharmaceutical University, Nanjing 210009,China; 2 Kunming General Hospital of Chengdu Military Region, Kunming 650032, China // Chinese J. of New Drugs. – 2007. – P. 20.
Biopharmaceutics Classifications System (BCS) / Ketoprofen. URL http://www.strinc.com // services / bcs / results/ cfm.
Classification of torasemide based on the Biopharmaceutics Classification System and evaluation of the FDA biowaiver provision for generic products of Class I drugs / M. Zahirul I. Khan etc. // J. of Pharmacy and Pharmacol. – 2006. – Vol. 58, Issue 11. – Р. 1475-1482.
Drugs and pharmaceutical sciences. Modified-Release Drag Delivery Technology / Ed. by M.J.Rathbone, J.Hadgraf, M.S.Roberts. – New York – London, 2008. – Vol. 151. – 538 p.
Drugs and the pharmaceutical Sciences. Pharmaceutical Process Scale-Up / Ed. by M.Levin. – New York – London, 2011. – Vol. 157. – 548 p.
Satish K. Nachaegari, Arvind K. Bansal // Pharm. Technol. – 2004. – P. 52-64.
Copyright (c) 2014 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).